<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Life sciences briefing: Wednesday, Nov. 7, 2007</title>
	<atom:link href="http://venturebeat.com/2007/11/07/life-sciences-briefing-wednesday-nov-7-2007/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/11/07/life-sciences-briefing-wednesday-nov-7-2007/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Wed, 25 Nov 2009 16:28:31 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: VentureBeat &#187; IPO roundup: Is the window slamming on life sciences?</title>
		<link>http://venturebeat.com/2007/11/07/life-sciences-briefing-wednesday-nov-7-2007/comment-page-1/#comment-778752</link>
		<dc:creator>VentureBeat &#187; IPO roundup: Is the window slamming on life sciences?</dc:creator>
		<pubDate>Thu, 07 Feb 2008 15:20:23 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/11/07/life-sciences-briefing-wednesday-nov-7-2007/#comment-778752</guid>
		<description>[...] at a discount in November &#8212; EnteroMedics (Nov. 14, now up three percent), ARYx Therapeutics (Nov. 7, now down 25 percent) and BioForm Medical (also Nov. 7, now down 29 [...]</description>
		<content:encoded><![CDATA[<p>[...] at a discount in November &#8212; EnteroMedics (Nov. 14, now up three percent), ARYx Therapeutics (Nov. 7, now down 25 percent) and BioForm Medical (also Nov. 7, now down 29 [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Aryx discounts IPO price, raises up to $58M for safer drugs</title>
		<link>http://venturebeat.com/2007/11/07/life-sciences-briefing-wednesday-nov-7-2007/comment-page-1/#comment-621224</link>
		<dc:creator>VentureBeat &#187; Aryx discounts IPO price, raises up to $58M for safer drugs</dc:creator>
		<pubDate>Wed, 07 Nov 2007 22:09:28 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/11/07/life-sciences-briefing-wednesday-nov-7-2007/#comment-621224</guid>
		<description>[...] our story about this Fremont, Calif. company in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story about this Fremont, Calif. company in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Medical aethetics co. BioForm Medical prices IPO below range, raises up to $92M</title>
		<link>http://venturebeat.com/2007/11/07/life-sciences-briefing-wednesday-nov-7-2007/comment-page-1/#comment-621168</link>
		<dc:creator>VentureBeat &#187; Medical aethetics co. BioForm Medical prices IPO below range, raises up to $92M</dc:creator>
		<pubDate>Wed, 07 Nov 2007 21:51:32 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/11/07/life-sciences-briefing-wednesday-nov-7-2007/#comment-621168</guid>
		<description>[...] our story about this San Mateo, Calif., wrinkle-filler maker in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story about this San Mateo, Calif., wrinkle-filler maker in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
